Stem Cell Innovations Files new Patent Application Regarding Pluripotent Stem Cell Production
News Jan 27, 2009
Stem Cell Innovations, Inc. announced that it has filed a new patent application for the production of pluripotent stem cells from primordial germ cells.
"We have been working for several years to develop a more effective method for producing stem cells from germ cells," said CEO James H. Kelly, PhD. "This filing was submitted to secure our intellectual property prior to publication in the scientific literature."
The Company has been developing PluriCells™ for use in drug discovery. "The method in this application provides for a substantial improvement in both the yield and quality of stem cells produced. It builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions," explained Kelly.
Eppendorf Hosts Second Stem Cell Community Day in DuesseldorfNews
The event brings together experts from industry and academia to discuss recent trends, achievements, and challenges in bioprocessing technologies for stem cell research. The conference is organized by leading life science company Eppendorf AG.READ MORE
Purine Synthesis in Neuron-Like Cells InvestigatedNews
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms.READ MORE